Tolerability and Steady-state Pharmacokinetics of BIA 6-512

NCT03093389 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: BIA 6-512
DRUG: Placebo

Sponsor

Bial - Portela C S.A.